Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine
Clinical trial NCT04069897 · COMPLETED
Trial details
- NCT number
- NCT04069897
- Sponsor
- St. Olavs Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2025-06-13
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.